Type I (insulin-dependent) diabetes mellitus results from the progressive destruction of insulin-producing pancreatic beta cells, which leads to the development of hypoinsulinaemia and hyperglycaemia [1±8]. It is believed that genetic factors are a major component in the aetiology of Type I diabetes because a strong association has been observed between susceptibility to Type I diabetes and specific alleles of the MHC class II genes [9±17]. Although genetic susceptibility seems to be a prerequisite, studies on the risk of developing Type I diabetes using genetically identical twins have shown that their concordance rate for the Diabetologia (2001) 
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Abstract
Type I (insulin-dependent) diabetes mellitus results from the progressive loss of pancreatic beta cells. Environmental factors are believed to play an important part in the development of Type I diabetes by influencing the penetrance of diabetes susceptibility genes. As one environmental factor, the virus has long been considered to play a part in this disease. To date 13 different viruses have been reported to be associated with the development of Type I diabetes in humans and in various animal models. The most clear and unequivocal evidence that a virus induces diabetes in animals comes from studies on the d variant of the encephalomyocarditis (EMC-D) virus in mice and the Kilham rat virus (KRV) in rats. The infection of genetically susceptible strains of mice with a high titre of EMC-D virus results in the development of diabetes within 3 days. This is largely due to the rapid destruction of beta cells by the replication of the virus within the beta cells. In contrast, the infection of mice with a low titre of EMC-D virus results in a limited replication of the virus before the induction of neutralizing anti-virus antibody and the subsequent recruitment of activated macrophages. The Src kinases, particularly hck, play an important part in the activation of macrophages and the subsequent production of tumour necrosis factor (TNF)-a, interleukin (IL)-1b and nitric oxide (NO), leading to the destruction of beta cells which results in the development of diabetes. The Kilham rat virus causes autoimmune diabetes in diabetes resistant (DR)-BB rats without infection of beta cells. The infection of DR-BB rats with KRV results in the disruption of the finely tuned immune balance of Th1-like CD45RC + CD4 + and Th2-like CD45RC
disease approaches only about 40 % [18] . This suggests that environmental factors such as viruses, dietary proteins, toxins and stress could be important aetiological determinants [19, 20] . Viruses, as an environmental factor, are considered to cause Type I diabetes for several reasons. An apparent seasonal incidence in the onset of acute Type I diabetes with a peak in the autumn was noted almost 70 years ago [21] . Diseases with seasonal incidences are often caused by viral infections. There have also been many anecdotal reports of a viral infection preceding or coinciding with the onset of Type I diabetes, as well as case reports of virus isolation from pancreata of acutely diabetic deceased patients and induction of diabetes in susceptible animals by infection with isolated viruses [22±25] . Epidemiological studies examining newly diagnosed, recent-onset Type I diabetes patients for the presence of virus-specific IgM antibodies have also suggested a role for viruses in the aetiology of Type I diabetes [26±29] . To date, about a half-dozen human viruses have been reported to be associated with human Type I diabetes. These include coxsackie B virus [23, 30, 31] , rubella virus [32, 33] , mumps virus [34, 35] , cytomegalovirus [36±38], Epstein-Barr virus [39, 40] and Varicella Zostar virus [41] (Table 1 ). In animals, including mice, rats, hamsters, cattle, pigs and nonhuman primates, nine viruses have been reported to be associated with the development of Type I diabetes. Encephalomyocarditis (EMC) virus [42, 43] , mengovirus [44] , reovirus [45] and retrovirus [46±48] are reported to be associated with Type I diabetes in mice; coxsackie B viruses, particularly B4, in mice [49, 50] and non-human primates [51] ; foot-andmouth virus in pigs and cattle [52] ; rubella virus in hamsters and rabbits [53, 54] ; bovine viral diarrheamucosal disease virus in cattle [55] ; and KRV in rats [56] (Table 1) .
In addition to natural and experimental infection of animals with viruses for the induction of diabetes, a virus-induced transgenic mouse model for studies on Type I diabetes has been developed and studied in depth [57±59] . On the basis of their findings, the authors proposed that an immune response against the determinant shared by the host and virus can evoke a tissue-specific immune response that is capable of eliciting cell and tissue destruction. The possible mechanism is the generation of cytotoxic cross-reactive effector lymphocytes or antibodies that recognize specific determinants on target cells [59] .
Viruses can also prevent diabetes. Lymphocytic choriomeningitis virus (LCMV) can prevent the de- velopment of autoimmune Type I diabetes in the BioBreeding (BB) rat, a spontaneously diabetic animal model [60] and mouse hepatitis virus (MHV) prevents the development of Type I diabetes in nonobese diabetic (NOD) mice [61] . In both naturally occurring and experimental infection of animals, viruses can be involved in the pathogenesis of Type I diabetes in at least two distinct ways. Firstly, viruses can directly infect and destroy insulin-producing pancreatic beta cells, resulting in Type I diabetes. Secondly, viruses can in some way trigger or contribute to the autoimmune destruction of beta cells. The most clear and unequivocal evidence that a virus induces Type I diabetes in animals comes from studies on EMC virus in mice [42, 43, 62, 63] and KRV in rats [56, 64±67] . The EMC-D virus is considered to be a primary agent that is selectively injurious to beta cells, whereas KRV is considered to be a triggering agent of beta cell-specific autoimmunity without the infection of beta cells. This review focuses on the two distinct pathogenic mechanisms for the development of diabetes by these two distinct viruses.
EMC virus-induced diabetes in mice
The encephalomyocarditis virus, which belongs to the picornavirus family (Piconaviridae), is the smallest single-stranded RNA virus. It is a naked icosahedron and the capsid is composed of a polyprotein, consisting of a single molecule of each of four polypeptides (viral protein [VP]1, 2, 3 and 4). The diabetogenic variant of the EMC virus selectively infects and replicates within the beta cells of genetically susceptible strains of mice. The replication of EMC virus in the beta cells results in macrophages being recruited into the pancreatic islets. The secretion of cytokines, such as interleukin (IL)-1, tumour necrosis factor (TNF)-a and nitric oxide (NO), from the activated macrophages results in the further destruction of the remaining beta cells, leading to diabetes in the mice.
Control of EMC virus-induced diabetes in mice by the viral and host genes
The M variant of EMC virus (EMC-M) induces a diabetes-like syndrome, characterized by hypoinsulinaemia, hyperglycaemia, glycosuria, polydipsia and polyphagia in genetically susceptible strains of mice [42] . Statistically significant differences in the incidence of diabetes were found between and within experimental groups of mice infected with EMC-M virus [68, 69] . Plaque purification of EMC-M virus resulted in the isolation of two stable variants, one highly diabetogenic (EMC-D), which produces diabetes in over 90 % of infected animals, and the other nondiabetogenic (EMC-B), which does not produce diabetes in any of the animals it infects [43] . The two variants could not, however, be distinguished antigenically by a sensitive plaque neutralization assay or by competitive radioimmunoassay [43] . Examination of the complete nucleotide sequences of the genomes of both variants showed a total of 14 nucleotide differences between them [70, 71] . Further investigation using several mutant viruses generated from stocks of both EMC-D and EMC-B variants found that only one amino acid, alanine (776 th amino acid on the polyprotein), is critical for the diabetogenicity of the EMC virus [72] . A ªGº base at nucleotide position 3155 (Ala[GCC]-776 on the polyprotein) is unique to all diabetogenic variants and an ªAº base at the same position (Thr[ACC]-776) is identical in all non-diabetogenic variants.
To determine whether the exchange of Ala 776 for Thr 776 , and vice versa, affects viral diabetogenicity, a new recombinant RNA technique was developed involving the creation of a chimeric RNA by attaching the poly(C) region of the viral RNA to the 5 ¢-truncated RNA transcript of the EMC viral cDNA [73] . Using this technique, site-specific mutagenesis was carried out at nucleotide position 3155 of the EMC viral genome and SJL/J mice were infected with the resulting chimeric EMC viruses. It was found that all of the Ala 776 -containing recombinant EMC viruses induced diabetes, whereas none of the Thr 776 -containing recombinant EMC viruses induced diabetes in genetically susceptible mice [74] .
To determine whether the substitution of other amino acids for Ala 776 had any effect on the diabetogenicity of EMC virus, all possible base permutations of either the first or second base position of codon 776 were constructed using site-specific mutation with appropriate oligonucleotides. These manipulations resulted in EMC viruses with alanine, threonine, serine, proline, aspartic acid or valine at position 776 of the EMC virus polyprotein. None of the viruses, with the exception of those containing Ala 776 , produced diabetes in infected SJL/J mice (Table 2), indicating the importance of alanine in EMC virus diabetogenicity [74] . Through these studies, it was found that a single amino acid at position 776 of the EMC virus polyprotein determines viral diabetogenicity. The change of a single amino acid (Ala®Thr) at amino acid position 776 of the polyprotein in diabetogenic EMC virus results in a loss of viral diabetogenicity. Similarly, the change of a single amino acid (Thr®Ala) at the same position in nondiabetogenic EMC virus results in a gain of viral diabetogenicity.
The next question was why the 776 th amino acid, Ala, is critical for EMC virus-induced diabetes in mice. This amino acid lies in the highly conserved, strongly hydrophilic patch of the VP1, which contains three proximal prolines (Pro-Thr-Gly-Thr-Pro-Ala 776 -Lys-Pro). This site has been identified as being involved in viral attachment to beta cells. The aminoacid change from Thr (EMC-B) to Ala (EMC-D) at this position reduces the hydrophilicity of the region by 37 %. Thus, this change, unique to the diabetogenic variant, seems to be responsible for the diabetogenicity of the EMC virus by increasing the efficiency of viral attachment to beta cells [75] . This hypothesis is supported by a previous finding [76] that six times more EMC-D virus than EMC-B virus attached to primary beta cells in male ICR Swiss mice.
To test this hypothesis, the binding capability of each of the recombinant chimeric EMC viruses to beta cells was determined. The recombinant chimeric EMC viruses containing Thr, Ser, Pro, Asp or Val at position 152 of the major capsid protein VP1 (amino acid position 776 of the polyprotein) bound poorly to beta cells. In contrast, recombinant chimeric EMC viruses containing Ala at position 152 of the VP1 bound efficiently to and infected b cells, resulting in the development of diabetes. Three-dimensional molecular modelling showed that the van der Waals interactions are greater and the residues surrounding position 152 of the VP1 are more closely packed in recombinant chimeric viruses containing Thr, Ser, Pro, Asp or Val at position 152 than in recombinant chimeric viruses containing Ala at the same position (Fig. 1) . The surface area surrounding Ala at position 152 of the VP1 is more accessible, thus increasing the availability of the binding sites for attachment to beta-cell receptors and resulting in viral infection and the development of diabetes [77] .
With respect to the genetic control of EMC virusinduced diabetes, only certain inbred strains of mice (SJL, SWR, DBA/1, DBA/2) develop diabetes, whereas other strains (C57BL/6, CBA, AKR, BALB/C) do not develop diabetes when infected with the EMC-M virus [78] . Susceptibility seems to be inherited as an autosomal recessive trait, because the F1 cross between diabetes-prone SWR/J mice and diabetes-resistant C57BL/6J mice was resistant to diabetes on infection with EMC virus, whereas more than 20 % of the F2 generation contracted diabetes on exposure to the virus. When resistant F1 generations were back-crossed with the resistant C57BL/6J parents, the resulting offspring were also resistant to the development of EMC virus-induced diabetes. In contrast, when the resistant F1 generation was back-crossed with the susceptible SWR/J parents, approximately 50 % of the resulting offspring contracted diabetes. The data are consistent with the idea that EMC virus-induced diabetes follows Mendelian inheritance and that susceptibility is controlled by a single locus [78] . More recent experiments, in combination with earlier data, have indicated that a single gene controlling susceptibility to EMC-D virus-induced diabetes in mice can operate by modulating the expression of viral receptors on the beta cells [79] .
Pathogenic mechanism of EMC-D virus-induced diabetes in mice
Earlier studies showed that the infection of a genetically susceptible mouse strain (i. e. SJL/J) with a high titre (5 10 5 plaque-forming units [PFU]/mouse) of EMC-D virus results in the development of diabetes within 3 days due to the rapid destruction of beta cells by viral replication in the cells before the induction of sufficient neutralizing antibody against EMC-D virus [43] . To determine whether T-cell suppression has any effect on EMC-D virus-induced diabetes, SJL/J mice were treated with anti-L3T4 antibody or antiLyt2 antibody or both before and after EMC-D virus infection (5 10 5 PFU/mouse). There was no statistically significant difference in the incidence of diabetes between the anti-T cell antibody-treated and untreated animals [80, 81] . To determine whether macrophages play any part in the destruction of beta cells in EMC-D virus-infected mice, SJL/J mice were treated with anti-macrophage antibody (anti-Mac-2) before and after EMC-D viral infection (1 10 5 PFU/mouse). The incidence of virus-induced diabe- tes in mice treated with anti-macrophage antibody was lower than that in the untreated mice, indicating that macrophages play an important part in the process of beta cell destruction in the EMC-D virus-infected SJL/J mice [81] . Natural viral infections in animals and humans generally involve, however, exposure to relatively low numbers of virus; exposure to the high viral titres used in the experiments described above would not be likely in nature. Thus, another animal model was established to study the immune mechanisms involved in the destruction of beta cells, in which mice were infected with a low dose (100 PFU/mouse) of EMC-D virus [82] . In mice infected with a low dose of EMC-D virus, macrophages play a central part in the destruction of beta cells, as activation of macrophages before viral infection results in a statistically significant increase in the incidence of diabetes and inactivation of macrophages before viral infection almost completely prevents EMC-D virus-induced diabetes [82] . Additional studies showed that the selective EMC-D viral infection of pancreatic beta cells results in an initial recruitment of macrophages into the islets (Fig. 2) , followed by infiltration by other immunocytes including T cells, natural killer (NK) cells and B cells [81] . Although these studies show that macrophages are involved in the destruction of beta cells, the part played by macrophages is not fully understood. Further study found that EMC-D virus infects macrophages and activates them, but does not replicate within the macrophages [83] . Because macrophages are known to produce soluble mediators, IL-1b, TNF-a and NO, the involvement of these mediators in the destruction of beta cells in mice infected with a low dose of EMC-D virus was investigated. The expression of IL-1b, TNF-a and inducible nitric oxide synthase (iNOS) was selectively detected in the pan- creatic islets of mice infected with a low dose of EMC-D virus. In addition, the treatment of EMC-D virus-infected mice with antibody against IL-1b or TNF-a or with the iNOS inhibitor, aminoguanidine, resulted in a significant decrease (p < 0.01) in the incidence of diabetes [84] . These results suggest that macrophage-derived soluble mediators play a critical part in the destruction of beta cells, leading to the development of diabetes in mice infected with a low dose of EMC-D virus. The molecular mechanism involved in the destruction of beta cells by these soluble mediators is, however, not known. Investigators have shown that IL-1b induces apoptosis through the induction of inducible nitric oxide synthase (iNOS) expression and NO production in rat islet cells [85±87] . Both IL-1b and TNF-a have been shown to increase the expression of Fas, which is involved in apoptosis [88] . Therefore, it is possible that the limited replication of EMC-D virus in beta cells results in the recruitment of macrophages activated by virus infection, and IL-1b and TNF-a, produced by activated macrophages in the pancreatic islets, induce the expression of Fas in the beta cells and/or induce iNOS expression and NO production that contribute to beta-cell death through apoptosis (Fig. 3) .
The above studies showed that macrophages activated by EMC-D virus produce the soluble mediators that play an important part in the destruction of beta cells. The mechanisms that activate macrophages are, however, not known. Further investigations were initiated to determine whether a tyrosine kinase signalling pathway might be involved in the EMC-D virus-induced activation of macrophages in vitro and, if so, whether treatment with a tyrosine kinase inhibitor in vivo might protect against EMC-D virusinduced diabetes. Inducible NOS was expressed at a higher level than either IL-1b or TNF-a in cultured macrophages activated by EMC-D virus. There was also high NO production in these macrophages but there was no progeny virus production [83] . These results suggest that EMC-D viral infection of macrophages does not produce progeny virus but could result in the activation of macrophages. The production of NO was clearly inhibited by the addition of tyrosine kinase inhibitors such as AG126. When the tyrosine phosphorylation of mitogen-activated protein (MAP) kinases, such as extracellular signal-regulated kinases (ERK) 1/2, p38 MAPK and c-Jun-terminal activation kinase (JNK), was examined in macrophages infected with EMC-D virus, it was found that these signalling molecules were clearly activated 5 h after infection.
Next, the effect of AG126 on the development of diabetes was examined in DBA/2 mice infected with a low dose of EMC-D virus. The incidence of diabetes decreased greatly in mice treated with AG126. In contrast, a related tyrosine kinase inhibitor, AG556, which failed to suppress the production of NO in infected macrophages in vitro, failed to prevent diabetes when given to EMC-D virus-infected DBA/2 mice [83] . Thus, the suppression of macrophage-derived NO in vitro and the prevention of diabetes are strongly correlated. The expression of IL-1b, TNF-a and iNOS in the pancreata of AG126-treated, EMC-D virus-infected DBA/2 mice was further analysed and it was found that the expression of these mRNAs was clearly suppressed in the pancreata of AG126-treated mice compared with vehicle-treated control mice [83] . This result indicates that the treatment of EMC-D virus-infected mice with a tyrosine kinase inhibitor (AG126) not only suppresses the expression of iNOS but also inhibits macrophage-derived cytokines such as IL-1b and TNF-a.
To further explore the signalling mechanisms in the activation of macrophages by EMC-D virus, the expression and activation of signal transduction molecules, particularly the Src family of tyrosine kinases including p53/56 lyn , p58/64 hck and p59 c-fgr , were examined in peritoneal macrophages from DBA/2 mice infected with a low dose of EMC-D virus. Of the Src family kinases tested, hck showed a large increase in autophosphorylation and phosphorylation of Sam 68 (a substrate for Src kinase) (Fig. 4) . In contrast to hck, the autophosphorylating activity of lyn and fgr were barely detected and phosphorylation of Sam 68 was not increased. The protein content of hck had a peak at 48 h after the infection of EMC-D virus (Fig. 4) . These results suggest that hck is involved in the activation of macrophages in mice infected with EMC-D virus. In addition, whether the tyrosine phosphorylation of hck contributes to hck activity was examined by western blot analysis of hck in immune complex precipitated with anti-phosphotyrosine antibody. It was found that tyrosine phosphorylation of hck peaked 48 h after infection, with the same kinetics as that of hck activity. Next, the tyrosine phosphorylation level of an adaptor protein, Vav, was examined at the time of the highest kinase activity of hck (at 48 hr after EMC-D virus infection), as hck is believed to mediate tyrosine phosphorylation of Vav. The tyrosine phosphorylation of Vav was increased at 48 h after viral infection. These results suggest that hck signalling plays a critical part in the activation of macrophages through the mediation of the adaptor protein, Vav, in mice infected with EMC-D virus.
On the basis of these observations, it is hypothesized that the infection of macrophages by EMC-D virus results in the activation of Src kinase, particularly hck. Src kinase might activate the MAP kinase signalling pathway through Raf, MEK1/2 and ERK1/2, MKK4 and JNK, or MKK and p38MAPK. It is also possible that ERK1/2 and JNK activate IkB kinase, resulting in IkB degradation and the activation of the transcription factor NFkB. Furthermore, JNK could activate the transcription factor c-Jun, and p38MAPK could activate the transcription factor AP-1. The activated transcription factors bind to the appropriate site of the promoter region for IL-1b, TNF-a or iNOS and stimulate the transcription of these genes (Fig. 5 ). The soluble mediators (i. e., IL1b, TNF-a, NO) produced by the activation of these genes work synergistically to kill beta cells by apoptosis leading to diabetes in genetically susceptible mice infected with a low dose of the EMC-D virus.
KRV-induced autoimmune diabetes in rats
The Kilham rat virus belongs to the parvovirus family. The parvovirus virion has a diameter of 18 to 26 nm and a relatively simple structure composed of three proteins and a linear, single-stranded DNA molecule. Parvoviruses replicate in the nucleus of dividing cells ± hence the predilection of these viruses for bone marrow, lymphoid organs, gut and the developing embryo ± and the genome becomes integrated with that of the infected cell. The KRV was originally isolated from a rat sarcoma and has been found to cause a fatal neonatal disease, physical deformities and mental retardation in newborn rats.
The KRV has been shown to cause autoimmune diabetes in diabetes-resistant BioBreeding (DR-BB) rats, without distinct infection of beta cells [56, 64] . Diabetes-prone (DP) BB rats, like NOD mice, spontaneously develop a diabetic syndrome that resembles human Type I diabetes in many respects [89] . The DP-BB rats are lymphopenic and 70±80 % of the animals become diabetic at about 120 days of age. In contrast to DP-BB rats, DR-BB rats, derived from DP progenitors, have normal lymphocyte numbers and phenotypes and usually do not develop diabetes. When 21 to 25-day-old DR-BB rats were infected with KRV, about 30 % of the animals developed autoimmune diabetes within 2±4 weeks after infection [56] . An additional 31 % showed evidence of lymphocytic insulitis without diabetes.
Role of macrophages in KRV-induced diabetes in DR-BB rats
The infection of beta cells is an absolute requirement for the development of EMC-D virus-induced diabetes in mice. In contrast, KRV can induce autoimmune diabetes in DR-BB rats without the infection of beta cells. The KRV infects lymphoid organs such as the spleen, thymus and lymph nodes. Diabetes-resistant BB rats harbour autoreactive T cells, which are naturally held silent by immunoregulatory control involving the RT6.1 + subset of T cells [90, 91] . Recent experimental data suggests that KRV infection leads to the activation of silent autoreactive T cells in DR-BB rats [65] . These activated T cells are thought to be specific for beta cells. The precise mechanisms by which KRV induces autoimmune Type I diabetes without the infection of beta cells are, however, poorly understood.
Recent investigation sought to determine whether macrophages and macrophage-derived cytokines play any part in the development of KRV-induced diabetes in DR-BB rats [66] . The inactivation of macrophages with liposomal dichloromethylene diphosphonate (lip-Cl 2 MDP), which is selectively toxic to macrophages, results in the near complete prevention of insulitis and diabetes in KRV-infected DR-BB rats. Measurement of the macrophage-derived cytokines IL-12, TNF-a and IL-1b showed a selective increase in expression after KRV infection in the splenic lymphocytes and pancreatic islet infiltrates. Measurement of CD4 + T cell-derived cytokines found that An imbalance between the Th1-type CD4 + and Th2-type CD4 + subsets is thought to play an important part in the development of autoimmune responses to beta cells. The expression of Th1-type cytokines, such as IL-2 and IFN-g, correlates with the development of autoimmune diabetes, whereas the expression of Th2-type cytokines, such as IL-4, correlates with the prevention of diabetes. The increased expression of Th1-type cytokines, but not Th2-type cytokines, observed in KRV-infected DR-BB rats could be the result of a selective increase in the expression of IL-12 produced by activated macrophages. To determine whether macrophages are essential for the initiation of KRV-induced diabetes in DR-BB rats, adoptive transfer experiments were undertaken. Concanavalin-A (ConA)-activated splenic lymphocytes isolated from macrophage-depleted DR-BB rats injected with KRV/poly I:C did not induce insulitis and diabetes in young DP-BB rats, indicating that the depletion of macrophages resulted in the loss of the ability to transfer diabetes. These studies show that macrophages and macrophage-derived cytokines play a critical part in the cascade of events leading to the destruction of beta cells, culminating in the development of autoimmune diabetes in KRV-infected DR-BB rats.
Role of T cells in KRV-induced autoimmune diabetes in DR-BB rats
It was still not clear how KRV causes the destruction of beta cells in DR-BB rats without infection of these cells. Molecular mimicry, such as the existence of a common epitope between a KRV-specific peptide and a beta-cell autoantigen, has been suggested as a mechanism for the initiation of beta-cell-specific autoimmune diabetes [56, 66] . If molecular mimicry is involved in the initiation of beta-cell-specific autoimmunity, then KRV antigen-specific T cells generated by KRV peptides might cross-react with beta cells and attack them, resulting in the development of insulitis and, subsequently, diabetes. To test this hypothesis, recombinant vaccinia virus (rVV) expressing KRV proteins was used because the wild-type strain of vaccinia virus does not induce insulitis or diabetes in DR-BB rats [56] and rVVs have been used as a vehicle for the expression of foreign proteins that successfully induced humoral and cell-mediated immune responses [92±94] . The rVVs expressing the KRV peptides VP1, VP2 (completely overlapped by VP3), non-structural protein (NS)1 or NS2 were constructed. When DR-BB rats were infected with the rVVs expressing the KRV peptides, it was found that each viral peptide was clearly expressed in the infected DR-BB rats, viral peptide-specific T cells were generated, and antibodies against the KRV peptides were also induced. None of the DR-BB rats, however, developed insulitis or diabetes [67] . This result indicates that molecular mimicry between KRV peptides and beta-cell-specific autoantigens in DR-BB rats is unlikely to be a mechanism by which KRV induces beta-cell-specific autoimmune diabetes.
Because the KRV proteins failed to induce autoimmune diabetes in DR-BB rats, an alternative hypothesis is that KRV infection of DR-BB rats disturbs the finely tuned immune balance and activate autoreactive T cells that are cytotoxic to beta cells, resulting in T-cell mediated autoimmune diabetes similar to that seen in DP-BB rats. To test this hypothesis, the CD4 + and CD8 + T cell populations were examined in the splenocytes of DR-BB rats after KRV infection. The percentage of CD8 + T cells increased considerably, whereas the percentage of CD4 + T cells decreased, although the absolute number of both CD4 + and CD8 + T cells was increased during KRV infec- tion. In addition, CD8 + T cells preferentially proliferated as compared with CD4 + T cells in KRV-infected DR-BB rats. When KRV-infected DR-BB rats were treated with OX-8 monoclonal antibody, the incidence of diabetes in these rats was significantly decreased (p < 0.01), indicating that CD8 + T cells are clearly involved in the destruction of beta cells. It has been reported that the treatment of DP-BB rats with anti-NK cell antibody failed to prevent diabetes whereas OX-8 monoclonal antibody treatment successfully prevented diabetes [95] . Therefore, it is more likely that CD8 + T cells play a major part in KRV-induced diabetes, although the possibility of the involvement of NK cells cannot be absolutely excluded, because OX-8 monoclonal antibody also depletes NK cells.
In the rat, CD4 + T cells can be divided into Th1-like CD45RC + CD4 + T cells, which express IL-2 and T cells, and that the activated effector T cells kill the beta cells, similar to the case in DP-BB rats. Therefore, infectious KRV, rather than KRV proteins expressed in recombinant vaccinia viruses, is absolutely required to disturb or breakdown the finely tuned immune balance, resulting in the upregulation of preexisting beta-cell-cytotoxic effector T cells.
Conclusion
Although a genetic predisposition seems to be necessary for the development of Type I diabetes, non-genetic environmental factors play an important part in the expression of the disease. Viruses, as one environmental factor, might be involved in the pathogenesis of Type I diabetes in at least two distinct ways. Firstly, viruses could directly infect and destroy beta cells or, secondly, viruses could in some way trigger beta-cell-specific autoimmunity and the autoimmune-mediated destruction of beta cells. The EMC-D virus is a primary agent that is selectively injurious to beta cells and KRV is a triggering agent of betacell-specific autoimmunity that leads to Type I diabetes without the direct infection of the beta cells. For EMC-D virus as a primary agent, two animal models have been established to study the pathogenic mechanisms involved in the destruction of beta cells. One model consists of mice infected with a high titre of EMC-D virus, in which diabetes develops as a result of the destruction of beta cells largely through the replication of the virus within the beta cells. The other model consists of mice infected with a low titre of EMC-D virus, in which diabetes develops by the destruction of beta cells through soluble mediators released from macrophages that the EMC virus infects and activates. From studies on low dose EMC-D virus-induced diabetes, it was found that macrophage-derived soluble mediators, such as IL-1b, TNF-a and iNOS, play a critical part in the destruction of beta cells in EMC-D virus-infected DBA/2 mice. In this latter model, the activated macrophages are major effectors that can kill beta cells. The tyrosine kinase signalling pathway is involved in the activation of macrophages by the EMC-D virus. Further studies found that signal transduction molecules, particularly a Src kinase, hck, are closely involved in macrophage activation. The treatment of EMC-D virus-infected mice with a Src kinase inhibitor, PP2, results in the inhibition of hck activity, a decrease in the production of TNF-a and iNOS in the macrophages and the subsequent prevention of diabetes. Further studies are needed to understand the molecular role of hck in the pathogenesis of EMC-D virus-induced diabetes using hck knockout mice.
The mechanism by which KRV, as a triggering agent for autoimmune diabetes, induced autoimmune Type I diabetes without the direct infection of beta cells was poorly understood. It had been suggest-ed that molecular mimicry between KRV peptides and beta-cell-specific autoantigens might be a mechanism for the initiation of beta-cell-specific autoimmune diabetes in DR-BB rats. In this scenario, KRV antigen-specific T cells generated by KRV infection might attack beta cells if there is a common epitope between a KRV protein and an autoantigen expressed on beta cells. Alternatively, KRV infection of DR-BB rats might selectively activate beta-cell-cytotoxic effector T cells, resulting in T-cell-mediated autoimmune diabetes similar to that seen in DP-BB rats. This latter hypothesis suggests that KRV infection of DR-BB rats might activate silent autoreactive T cells, which are normally regulated by regulatory cells such as the RT6.1 + subset of T cells. The breakdown of the immune balance as a consequence of KRV infection might result in the selective activation of autoreactive T cells that are cytotoxic to beta cells, leading to autoimmune diabetes in DR-BB rats.
Through the results of a set of experiments designed to test these two hypotheses, it is concluded that KRV-induced autoimmune diabetes in DR-BB rats is not due to molecular mimicry but due to the breakdown of the finely tuned immune balance of Th1-like CD45RC + CD4 + and Th2-like CD45RC -CD4 + T cells, resulting in the selective activation of beta-cell-cytotoxic effector T cells (Fig. 7) . Further studies are needed, however, to understand the precise role of these effector T cells in the destruction of beta cells and the development of these cells in KRV-infected DR-BB rats. + T cells also activates CD8 + T cells. In addition, KRV activates macrophages which secrete IL-12, which also activates Th1-type CD4 + T cells. Thus, there is a substantial increase in Th1-type CD4 + T cells and, subsequently, an increase in CD8 + T cells. Through this process, the finely tuned immune balance can be broken down, resulting in the upregulation of effector T cells (Th1-type CD4 + and CD8 + T cells), leading to the destruction of beta cells
